# NHS National Generic Pharmaceuticals Wave 13

> A sourced UK public sector contract award published by ATAMIS LTD.

## Key facts

- Buyer: [ATAMIS LTD](/buyers/atamis-ltd/contract-awards)
- Supplier: [Pfizer Ltd](/suppliers/pfizer/public-sector-contract-awards)
- Award value: £469,741,550
- Tender value: £469,741,550
- Award date: 30 November 2021
- Published: 3 August 2022
- Contract start: 1 February 2022
- Contract end: 31 May 2024
- Stage: awarded
- Procurement category: goods
- Notice ID: f872d76f-37e6-4b7e-b25e-c952ac8a42eb-560066
- OCID: ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be

## Description

Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend \(at the Authority's sole discretion\) for a period or periods up to a total of 48 months\. Potential periods of call-offs under the framework agreement: Transition \(Everolimus\) CESW: 1 March 2022 - 30 September 2023 \(19 months\) LSNE: 1 March 2022 - 31 January 2023 \(11 months\) NWLN: 1 March 2022 - 31 January 2023 \(11 months\) Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 \(27 months\) Hospital Only Products CESW: 1 February 2022 - 30 September 2023 \(20 months\) LSNE: 1 February 2022 - 31 May 2024 \(28 months\) NWLN: 1 February 2022 - 31 January 2023 \(12 months\)

## Related contract awards

- [Avon & Bedford Court 76-92 Church Street Weybridge, Surrey, KT13 8DL](/contracts/ocds-b5fd17-dabfc9e7-cefc-4980-81a5-e3546200dd50) — ATAMIS LTD
- [UKRI-5133 MRC LMB Microscope Servicing](/contracts/ocds-b5fd17-f2c1e0a3-93e6-4530-a6ea-b4044e7f225c) — ATAMIS LTD
- [Data Reporting & Cloud Support](/contracts/ocds-b5fd17-47ee6157-4143-4c24-b458-1ce3b7b7f4ed) — ATAMIS LTD
- [Assurance of SW's Management Approach Policies](/contracts/ocds-b5fd17-4e1daabd-efc6-48cb-9214-3b41a0ba1b8e) — ATAMIS LTD
- [Pneumococcal vaccine for adults and at risk groups \(2025\)](/contracts/ocds-b5fd17-192951c1-2095-4648-9aee-ffa587e6fbcf) — UK Health Security Agency
- [NHS Framework - Blood Disorders including Haemophilia A and B - July 2024](/contracts/ocds-b5fd17-78480ca7-506a-4fbd-ab2d-b535c8904519) — NHS England
- [Bleeding Disorders including Haemophilia B](/contracts/ocds-b5fd17-3223ee06-289a-4576-a570-9458205ac102) — NHS England
- [NHS National Generic Pharmaceuticals Wave 13](/contracts/ocds-b5fd17-3856df43-01d6-4042-a1e6-a1524397d100) — ATAMIS LTD
- [Twilio SMS Authentication](/contracts/ocds-b5fd17-b827efaf-bc60-408b-a3cf-61c184235144) — Department for Work and Pensions
- [Award of Conductive Energy Devices and Associated Equipment](/contracts/ocds-b5fd17-1908f0dd-8662-49a0-b6ab-b4c7a997fe5b) — Ministry of Justice
- [WSFT - Capital Purchase - IT - Dell laptops](/contracts/ocds-b5fd17-7526b81a-7a2b-4360-bb23-85432986289d) — West Suffolk NHS Foundation Trust
- [Provision of Office Supplies](/contracts/ocds-b5fd17-5e1046dd-5ef8-47df-b38b-5818911c0973) — Government Commercial Agency

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/f872d76f-37e6-4b7e-b25e-c952ac8a42eb-560066)